首页> 美国政府科技报告 >Preparation of Burkholderia pseudomallei Polysaccharide-CRM197 Conjugate, a Potential Vaccine Candidate for Glanders and Melioidosis
【24h】

Preparation of Burkholderia pseudomallei Polysaccharide-CRM197 Conjugate, a Potential Vaccine Candidate for Glanders and Melioidosis

机译:Burkholderia pseudomallei多糖-CRm197结合物的制备,一种潜在的鼻疽和类鼻疽疫苗候选疫苗

获取原文

摘要

Current ststus treatment of melioidosis and glanders: (1) Burkholderia mallei and B. pseudomallei are the causative agents for glanders and melioidosis, respectively; (2) Both of these organisms have been considered as potential agents for biological warfare and biological terrorism; (3) Currently, these infections are treated with antibiotics; (4) Currently, no vaccines are available for protection against glanders and melioidosis.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号